178 related articles for article (PubMed ID: 34286514)
121. HOTAIR/miR-1277-5p/ZEB1 axis mediates hypoxia-induced oxaliplatin resistance via regulating epithelial-mesenchymal transition in colorectal cancer.
Weng X; Liu H; Ruan J; Du M; Wang L; Mao J; Cai Y; Lu X; Chen W; Huang Y; Zhi X; Shan J
Cell Death Discov; 2022 Jul; 8(1):310. PubMed ID: 35798695
[TBL] [Abstract][Full Text] [Related]
122. PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression.
Liu Y; Xie C; Li T; Lu C; Fan L; Zhang Z; Peng S; Lv N; Lu D
BMC Womens Health; 2023 Mar; 23(1):104. PubMed ID: 36915057
[TBL] [Abstract][Full Text] [Related]
123. Role of UPF1 in lncRNA-HEIH regulation for hepatocellular carcinoma therapy.
Cha H; Kim M; Ahn N; Jeong SD; Ignatova E; Chi SW; Kim HH; Hwang J
Exp Mol Med; 2024 Feb; 56(2):344-354. PubMed ID: 38297160
[TBL] [Abstract][Full Text] [Related]
124. The Value of Emerging Prostate Cancer-associated lncRNA PCGEM1 in Various Tumors.
Lv X; Zhang M; Xu W
Mini Rev Med Chem; 2023; 23(22):2090-2096. PubMed ID: 36915991
[TBL] [Abstract][Full Text] [Related]
125. Submicron silica particles have cytotoxicities on hepatocellular carcinoma, non-small cell lung cancer and breast cancer by unified regulating the XLOC_001659/miR-98-5p/MAP3K2-mediated pathway.
Shi J; Ci Y; Zheng Y; Chen W; Chen X
Toxicol Res (Camb); 2021 Aug; 10(4):824-834. PubMed ID: 34484674
[TBL] [Abstract][Full Text] [Related]
126. Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma.
Kang X; Huo Y; Jia S; He F; Li H; Zhou Q; Chang N; Liu D; Li R; Hu Y; Zhang P; Xu A
Front Oncol; 2022; 12():939605. PubMed ID: 35875091
[TBL] [Abstract][Full Text] [Related]
127. Transcription Factor ELK3 Promotes Stemness and Oxaliplatin Resistance of Glioma Cells by Regulating RNASEH2A.
Mei Y; Chen D; He S; Ye J; Luo M; Wu Q; Huang Y
Horm Metab Res; 2023 Feb; 55(2):149-155. PubMed ID: 36638810
[TBL] [Abstract][Full Text] [Related]
128. SMC4 enhances the chemoresistance of hepatoma cells by promoting autophagy.
Zhang SR; Li J; Chen JX; Chen G; Chen JY; Fu HW; Zhou B
Ann Transl Med; 2022 Dec; 10(24):1308. PubMed ID: 36660610
[TBL] [Abstract][Full Text] [Related]
129. lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin.
Wang X; Zhang H; Yin S; Yang Y; Yang H; Yang J; Zhou Z; Li S; Ying G; Ba Y
EMBO Rep; 2022 Jan; 23(1):e53140. PubMed ID: 34779552
[TBL] [Abstract][Full Text] [Related]
130. Long non-coding RNA FAM133B-2 represses the radio-resistance of nasopharyngeal cancer cells by targeting miR-34a-5p/CDK6 axis.
Huang D; Zhu X; Wang Y; Yu H; Pu Y
Aging (Albany NY); 2020 Sep; 12(17):16936-16950. PubMed ID: 32889799
[TBL] [Abstract][Full Text] [Related]
131. Downregulation of LncRNA GCLC-1 Promotes Microcystin-LR-Induced Malignant Transformation of Human Liver Cells by Regulating GCLC Expression.
Huang X; Su Z; Li J; He J; Zhao N; Nie L; Guan B; Huang Q; Zhao H; Lu GD; Nong Q
Toxics; 2023 Feb; 11(2):. PubMed ID: 36851037
[TBL] [Abstract][Full Text] [Related]
132. Genome-wide analysis of ETV1 targets: Insights into the role of ETV1 in tumor progression.
Eid W; Abdel-Rehim W
J Cell Biochem; 2019 Jun; 120(6):8983-8991. PubMed ID: 30629294
[TBL] [Abstract][Full Text] [Related]
133. ATR-dependent ubiquitin-specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance.
Tang J; Long G; Xiao D; Liu S; Xiao L; Zhou L; Tao Y
MedComm (2020); 2023 Dec; 4(6):e463. PubMed ID: 38124786
[TBL] [Abstract][Full Text] [Related]
134. Induction of resistance to oxaliplatin in cancer by a microRNA/Fem1B/Gli1 pathway.
Su YC; Metzen LT; Vélez LM; Bournique E; Seldin M; Buisson R; Kuo WW; Huang CY; Kaiser P
Am J Cancer Res; 2023; 13(12):6011-6025. PubMed ID: 38187042
[TBL] [Abstract][Full Text] [Related]
135. Lentinan Enhances the Function of Oxaliplatin on the Esophageal Tumors by Persuading Immunogenic Cell Death.
Huo X; Pei Z; Wang W; Liu Y; Sun J; Wang H; Ai N
Comput Math Methods Med; 2022; 2022():2296574. PubMed ID: 35844448
[TBL] [Abstract][Full Text] [Related]
136. METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway.
Wang Y; Hong Z; Song J; Zhong P; Lin L
Front Pharmacol; 2023; 14():1257410. PubMed ID: 37822880
[TBL] [Abstract][Full Text] [Related]
137. Long Noncoding RNA XIST Promotes Resistance to Lenvatinib in Hepatocellular Carcinoma Cells via Epigenetic Inhibition of NOD2.
Duan A; Li H; Yu W; Zhang Y; Yin L
J Oncol; 2022; 2022():4537343. PubMed ID: 36304988
[No Abstract] [Full Text] [Related]
138. Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptide.
Jing R; Wang Q; Chen L; Li G; Li R; Zhang L; Zhang H; Zuo B; Seow Y; Qiao X; Wang B; Xu J; Chen J; Song T; Yin H
Biomaterials; 2022 Oct; 289():121758. PubMed ID: 36049426
[TBL] [Abstract][Full Text] [Related]
139. FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis.
Li Y; Chen J; Wang B; Xu Z; Wu C; Ma J; Song Q; Geng Q; Yu J; Pei H; Yao Y
Drug Resist Updat; 2023 Mar; 67():100926. PubMed ID: 36682222
[TBL] [Abstract][Full Text] [Related]
140. HSP90a promotes the resistance to oxaliplatin in HCC through regulating IDH1-induced cell competition.
Wang S; Cheng H; Huang Y; Li M; Gao D; Chen H; Su R; Guo K
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119680. PubMed ID: 38280407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
